哥伦比亚外交部长辞职 智通财经7月4日电，据新华社报道，哥伦比亚外交部长劳拉·萨拉维亚3日在社交媒体上发布一封致该国 总统佩特罗的公开信，宣布辞去外长职务。佩特罗随后表示接受其辞职。萨拉维亚在信中说，辞职原因 是近来政府作出了一些她"无法认同的决定"，出于"个人立场的一贯性和对机构的尊重"，她无法再继续 执行当前路线。佩特罗随后在社交媒体上表示接受萨拉维亚的辞职。他称赞萨拉维亚在竞选期间扮演 了"至关重要"的角色，并肯定了她在政府工作中展现出的聪慧。萨拉维亚在佩特罗政府中先后担任多个 职务，并于2025年1月就任外交部长。今年2月9日，佩特罗在社交媒体上表示，他已要求多名部长和行 政部门主管辞职。佩特罗写道："内阁将有一些调整，以更好落实人民要求的计划项目。"当天晚些时 候，萨拉维亚曾递交辞呈，但最终获得留任。 ...

Core Insights - The article discusses the author's background and experience in journalism and the financial sector, emphasizing a decade of reporting experience and a focus on economic issues [3]. Group 1 - The author has a diploma in journalism from Lethbridge College and has over ten years of reporting experience [3]. - The author has covered territorial and federal politics in Nunavut, Canada, showcasing a diverse reporting background [3]. - Since 2007, the author has worked exclusively within the financial sector, starting with the Canadian Economic Press [3].

金十数据7月4日讯，哥伦比亚外交部长劳拉·萨拉维亚3日在社交媒体上发布一封致该国总统佩特罗的公 开信，宣布辞去外长职务。佩特罗随后表示接受其辞职。萨拉维亚在信中说，辞职原因是近来政府作出 了一些她"无法认同的决定"，出于"个人立场的一贯性和对机构的尊重"，她无法再继续执行当前路线。 佩特罗随后在社交媒体上表示接受萨拉维亚的辞职。他称赞萨拉维亚在竞选期间扮演了"至关重要"的角 色，并肯定了她在政府工作中展现出的聪慧。 哥伦比亚外交部长辞职 ...

Group 1 - The Company, EQV Ventures Acquisition Corp. II, successfully closed its initial public offering (IPO) of 42,000,000 units, which was upsized from 35,000,000 units, at a price of $10.00 per unit, generating total gross proceeds of $460 million before deductions [1] - The Company's units began trading on the New York Stock Exchange (NYSE) under the ticker symbol "EVACU" on July 2, 2025 [2] - Each unit consists of one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant allowing the holder to purchase one Class A ordinary share at a price of $11.50 per share [3] Group 2 - BTIG, LLC acted as the sole book-running manager for the offering, and the offering was made only by means of a prospectus [4] - Registration statements related to these securities were filed with the U.S. Securities and Exchange Commission (SEC) and became effective on July 1, 2025 [4]

周四（7月3日）纽约尾盘，美元兑日元涨0.93%，报144.99日元，日内交投区间为143.45-145.23日元， 北京时间20:30发布美国非农就业报告后，该货币对打破日内稍早的窄幅低位震荡状态，瞬间从143.80 日元一线拉升至145日元上方。 ...

截至2025年7月3日收盘，聚合顺(605166)报收于11.31元，上涨0.35%，换手率2.24%，成交量7.05万手， 成交额7944.47万元。 董秘最新回复 投资者： 董秘您好！请问聚合顺最近几年新上PA6聚合项目，主设备（聚合管、反应釜）供应商是哪 家？谢谢！ 董秘： 尊敬的投资者：您好！感谢您对公司经营和生产的关心。公司根据工艺、生产及综合需要，会 综合评估设备相关供应商，最终保证技术工艺的质量和效率。感谢您的关注！ 当日关注点 减少注册资本通知债权人的公告 公司于2024年10月8日召开第三届董事会第二十九次会议，审议通过了《关于以集中竞价交易方式回购 股份的预案》。2024年11月7日召开的2024年第四次临时股东大会审议通过了回购预案。截至2025年3月 交易信息汇总：7月3日主力资金净流出1126.59万元，占总成交额14.18%。 公司公告汇总：聚合顺新材料股份有限公司为子公司提供总计16500万元、2200万元、3300万元的 担保，且公司及子公司对外担保总额超过最近一期经审计净资产100%。 公司公告汇总：截至2025年6月30日，"聚合转债"和"合顺转债"的转股比例分别为0.19 ...

Core Viewpoint - Hims & Hers Health, Inc. is facing a class action securities lawsuit due to alleged securities fraud that occurred between April 29, 2025, and June 23, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Hims was involved in the deceptive promotion and sale of illegitimate versions of Wegovy®, which jeopardized patient safety [2]. - It is alleged that this situation posed a significant risk of termination of the Company's collaboration with Novo Nordisk [2]. - The defendants' positive statements regarding the Company's business and prospects are claimed to be materially misleading and lacking a reasonable basis [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until August 25, 2025, to request to be appointed as lead plaintiff [3]. - Participation in the lawsuit does not require any out-of-pocket costs or fees for class members [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

一场覆盖上海全城的节能宣传周于近期落幕。在以"节能增效，焕'新'引领"为主题的相关系列活动中， 从特斯拉上海储能超级工厂的"赛博光漪池"到杨树浦电厂旧址的"零碳智慧综合能源中心"，中国证券报 记者在调研过程中深刻感受到，上海正以惊人的速度编织一张绿色产业网络。 ● 本报记者乔翔 聚焦绿色探索 6月23日至29日，由上海市经济和信息化委员会联合各区、委办、企业，以"节能增效，焕'新'引领"为 主题，共同举办节能宣传周系列活动。在此次活动中，记者走进上海各大企业，以进一步了解相关企业 在绿色低碳新赛道上的最新成果。 走进特斯拉上海储能超级工厂，角落中一片波光粼粼的"赛博光漪池"格外吸引人，池中睡莲与美人蕉绽 放、锦鲤游弋，和谐共生。 "这处自然角落，正是特斯拉绿色制造的鲜活注脚。"据特斯拉相关负责人介绍，池中每一滴水，均来自 工厂废水处理系统的"再生水源"，水质不仅超过上海市三级排放标准，实际运行指标也大幅优于环保限 值，成为滋养生态的清澈"源泉"。 记者了解到，这并非特斯拉首次将工业废水转化为生态景观，厂区内的网红打卡点锦鲤鱼缸早已成为其 环保实践的缩影——鱼缸里用来养锦鲤的水，都是经过处理的工厂废水。 走进储 ...

Core Viewpoint - A class action securities lawsuit has been filed against Reddit, Inc. for alleged securities fraud affecting investors between October 29, 2024, and May 20, 2025 [1][2]. Group 1: Lawsuit Details - The complaint alleges that the defendants made false statements regarding the impact of changes in Google Search's algorithm, which led to a significant reduction in traffic to Reddit [2]. - It is claimed that the defendants were aware that users were finding answers directly on Google Search, leading to a decrease in visits to Reddit, contrary to their public statements about user rates and advertising revenues [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until August 18, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require this [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Viewpoint - Iovance Biotherapeutics, Inc. is facing a class action securities lawsuit due to alleged securities fraud that negatively impacted investors between May 9, 2024, and May 8, 2025 [1][2]. Group 1: Allegations and Financial Impact - The lawsuit claims that Iovance provided misleadingly positive statements while concealing material adverse facts about its growth potential and ability to meet demand for its treatments [2]. - On July 25, 2024, Iovance announced a reduction in its revenue guidance for fiscal year 2024, attributing this to maintenance issues, lower-than-expected Proleukin sales, and a variable pace of treatment initiation at approved centers [2]. - Following the announcement, Iovance's stock price plummeted from $3.17 per share on May 8, 2025, to $1.75 per share on May 9, 2025, marking a decline of approximately 44.8% in one day [2]. Group 2: Legal Proceedings and Participation - Investors who suffered losses during the specified period have until July 14, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees [3]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States [4].